Y Innovations and iWisdom are pleased to announce that they have joined forces in a transformative collaboration to accelerate biopharma innovation, creating true innovation hubs from discovery to commercialization in emerging regions.
The initial focus will be the strategic development and commercialization of three (3) assets in the gene therapy and delivery fields in several emerging regions. This collaboration combines Y Innovation’s expertise in early-stage development and financing with iWisdom’s strength in commercialization and global market access. By fast-tracking the development of critical therapies and technologies, establishing key infrastructure, and creating thriving biopharma hubs, this collaboration has the potential to connect and transform these industries in emerging regions and translate to impactful outcomes on the world stage.
"Partnering with Y Innovations, a powerhouse with an impressive track record and proven capabilities in advancing early-stage biopharma innovation, takes this vision to new heights. Together, we’re building a stronger, more impactful gateway that addresses unmet regional needs" said Ishil Ozturk, Founder and Managing Director of iWisdom.
“With our expertise in early-stage development and iWisdom’s unmatched capability in commercialization and speed to market at a global scale, this collaboration is set to fast-track the journey from discovery to delivery," said Megan Yung, Founder and CEO of Y Innovations Group.
Together, their complementary strengths will enhance and fortify existing partnerships with stakeholders, driving impactful outcomes while helping to position the emerging regions in which they operate in as vital players in global biopharma innovation.
About iWisdom
At iWisdom, we are true gateway catalysts, connecting regional potential to global innovation in the biopharma and healthtech sectors. With our expansive and invaluable networks, combined with over 120 years of expertise in commercialization at a global scale, we position ourselves as the ideal partners for transformative growth. Acceleration and value maximization are at the heart of everything we do. By leveraging our billion-dollar launch track record and commitment to speed-to-outcomes, we empower biopharma innovators to achieve transformative growth and sustainable success. Specializing in guiding assets from early development to market success, we operate on three foundational pillars across all stages of development: Commercialize, Advise, Invest.
About Y Innovations Group
Our focus is in driving early-stage innovation and turning groundbreaking ideas into reality. Y Innovations Group combines the scientific and technological background of our subject matter experts with the market insights and operational expertise of our experienced industry veterans to provide impactful value to our clients, portfolio companies, and partners. All three organizations under YI Group operate across the artificial intelligence, biotech, and energy sectors. The Firm consults and advises on strategic planning and analysis, intellectual property strategy, market research and competitive intelligence, and more to provide actionable solutions to companies. The Studios seeks to grow early-stage companies in the Y Innovations ecosystem by pairing them with strategic operational experts to accelerate their path from early ideation to market acceptance. Yung Ventures seeks to provide capital support to companies at various stages in their life cycle.
コメント